Old Web
English
Sign In
Acemap
>
authorDetail
>
Parshottam Koradia
Parshottam Koradia
Internal medicine
Medicine
open label study
Coronavirus disease 2019
Gastroenterology
4
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Pegylated Interferon-α2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
2021
International Journal of Infectious Diseases
Shashi Bhushan B L
Sunil Wanve
Parshottam Koradia
Vinay Bhomia
Pravin Soni
Sisir Chakraborty
Akash Khobragade
Shashank R. Joshi
Sanjeev Kumar Mendiratta
Kevin Kumar Kansagra
Anurag Parihar
Sunil Sharma
Jatin Patel
Show All
Source
Cite
Save
Citations (0)
Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].
2021
International Journal of Infectious Diseases
Anuja Pandit
Nirav Bhalani
B.L. Shashi Bhushan
Parshottam Koradia
Shweta Gargiya
Vinay Bhomia
Kevinkumar Kansagra
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study.
2021
International Journal of Infectious Diseases
Anuja Pandit
Nirav Bhalani
B.L. Shashi Bhushan
Parshottam Koradia
Shweta Gargiya
Vinay Bhomia
Kevinkumar Kansagra
Show All
Source
Cite
Save
Citations (15)
Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study
2019
Expert Review of Anti-infective Therapy
Parshottam Koradia
Shital Kapadia
Yamini Trivedi
Gajendrasinh Chanchu
Ashton Harper
Show All
Source
Cite
Save
Citations (16)
1